<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71153-2012-1
</NDCCode>
<PackageDescription>
44 mL in 1 TUBE (71153-2012-1)
</PackageDescription>
<NDC11Code>
71153-2012-01
</NDC11Code>
<ProductNDC>
71153-2012
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
General Protection
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Avobenzone,octinoxate,octisalate,octocrylene
</NonProprietaryName>
<DosageFormName>
GEL
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20170201
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part352
</ApplicationNumber>
<LabelerName>
Cross-Brands Manufacturing LLC
</LabelerName>
<SubstanceName>
OCTISALATE; OCTINOXATE; AVOBENZONE; OCTOCRYLENE
</SubstanceName>
<StrengthNumber>
3; 7.5; 3; 2
</StrengthNumber>
<StrengthUnit>
g/mL; g/mL; g/mL; g/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-09-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>